[CPDD Roster]

The Child Psychopathology and Developmental Disabilities [CPDD] Study Section reviews applications on developmental, psychopathological, and substance use disorders in infants, children, adolescents, and adults with disorders originating in early development. Emphasis is placed on cognitive, behavioral, social, family, and neurobiological aspects of a] developmental disabilities such as autism and mental retardation; brain injury and communication and learning disabilities; b] disorders of behavioral and/or emotional regulation such as attention deficit hyperactivity disorder, Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), mood disorders, suicide, anxiety and traumatic stress disorders, conduct disorder, eating disorders, personality disorders, and psychoses; c] substance use disorders; and d] the relationship among these disorders over time.

Specific areas covered by CPDD:

• The short- and long-term development of infants and children with identified risk factors including early brain injury, prematurity, low birth weight, genetic risk, environmental risk and teratogens [including substance abuse], as well as the role of familial and psychosocial stress on the behavior and development of compromised children
• Disorders of cognitive, sensory, perceptual and motor development: Included are disorders such as mental retardation, autism, attention deficit and learning disabilities
• Child and adolescent psychopathology: Studies of diagnosis, etiology, comorbidity, clinical course and outcomes
• Neurobiologic, genetic, and other biobehavioral factors: Biological, genetic and neural factors underlying developmental disorders and child psychopathology. Included are genetic and family studies, neuropathological studies, neurochemical and neuroimaging studies, and studies of teratogenic exposures, when the emphasis is on the relationship between these factors and clinical or functional outcomes over time
• Congenital and acquired disorders that affect brain development and behavior: Studies of disorders that affect development because of CNS impairments, including congenital disorders such as spina bifida; known genetic disorders such as Williams syndrome, Down syndrome, Fragile X; acquired disorders such as Traumatic Brain Injury, CNS tumors, cerebral palsy, and focal lesions; effects of CNS treatment on development
• Teratogens and substance abuse: Studies of prenatal exposure to alcohol, cocaine, and other drugs; prenatal and postnatal effects of lead, mercury, and other toxins; environmental factors associated with neural tube defects
• Treatment and rehabilitation: Studies that address psychosocial, behavioral, educational, and rehabilitative primary or adjunctive interventions for children with these disorders

CPDD has the following shared interests within the BBBP IRG:

• Studies of basic learning principles and pharmacology applied to self-injurious behavior may be assigned to BRLE.
• Studies of basic mechanisms underlying affect and stress responses in normal and disordered populations may be assigned to MESH. Studies that examine disorders more broadly may be assigned to CPDD.
• Studies of symptoms, disorders, and interventions specifically related to language/communication, including specific language impairment and dyslexia, may be assigned to LCOM. Studies that consider a broader range of developmental abnormality may be assigned to CPDD.
• Studies of basic cognitive/perceptual mechanisms underlying developmental disorders may be assigned to CP. Studies that examine developmental disorders more broadly may be assigned to CPDD. All studies of preventive and treatment interventions may be assigned to CPDD.
• Studies of disorders in adult or adolescent samples may be assigned to APDA. Studies of the longitudinal course of those disorders may generally be assigned to CPDD. Studies of processes common to both childhood and adult disorders may be assigned to either APDA or CPDD.
• Studies of symptoms, disorders, and interventions specifically related to motor function may be assigned to MFSR. Studies that consider a broader range of developmental abnormality may be assigned to CPDD.
  

CPDD has the following shared interests outside the BBBP IRG:

• With the Genes, Genomes and Genetics [GGG] IRG:  Studies of genetic mechanisms in child disorders in which the emphasis is not behavioral may be assigned to the GGG IRG. 
  
  
• With the Health of the Population [HOP] IRG:  Studies that focus on the individual level of analysis in child disorders and disability may be reviewed in CPDD.   Applications with studies nested within multi-level, multi-contextual studies focusing on the interrelationships among individual, familial [biologic, genetic and/or environmental factors], social and cultural factors and behaviors in the etiology, natural history, and consequences of disorders and diseases may be assigned to the HOP IRG.
  
  
• With the Risk, Prevention and Health Behavior [RPHB] IRG:  Studies concerned with particular disorders in children or adolescents or that focus on treatment and interventions for developmental disorders and disability may be assigned to CPDD.   Applications that focus on preventive interventions targeting interpersonal processes, as well as those focusing on understanding risk and protective factors, whether in typical, risk or disordered groups may be assigned to the RPHB IRG.
  
  
• With the Brain Disorders and Clinical Neuroscience [BDCN] IRG:  Studies of developmental disabilities that are primarily behavioral in emphasis may be reviewed in CPDD.  Studies that focus on physiological processes such as neural mechanisms underlying developmental or psychiatric disorders may be assigned to the BDCN IRG.  These often involve animal models. 
  
  
• Study Sections in NIAAA, NIDA, and NIMH may review applications in treatment and health services research. For more information, see the Institutes' respective web sites.